Buchumschlag

NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells

Type 2 diabetes mellitus (T2DM) remains one of the most pressing health issues facing modern society. Several antidiabetic drugs are currently in clinical use to treat hyperglycaemia, but there is a need for new treatments that effectively restore pancreatic islet function in patients. Recent studie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Malgorzata Cyranka (VerfasserIn), Thomas Monfeuga (VerfasserIn), Natascia Vedovato (VerfasserIn), Chelsea M Larabee (VerfasserIn), Anandhakumar Chandran (VerfasserIn), Enrique M Toledo (VerfasserIn), Heidi de Wet (VerfasserIn)
Format:	Buch
Veröffentlicht:	Frontiers Media S.A., 2022-04-01T00:00:00Z.
Schlagworte:	article
Online-Zugang:	Connect to this object online.
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

NMDA Receptor Antagonists for Treatment of Depression
von: Zeynep Ates-Alagoz, et al.
Veröffentlicht: (2013)

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
von: A. P. Pereverzev, et al.
Veröffentlicht: (2019)

NMDA Receptor-Antagonistic Properties of Hyperforin, a Constituent of St. John's Wort
von: Vikas Kumar, et al.
Veröffentlicht: (2006)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.
von: Higo Fernando Santos Souza, et al.
Veröffentlicht: (2019)

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
von: Ayodeji Olatunde Egunlusi, et al.
Veröffentlicht: (2024)

Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists
von: Tatsuo Nagata, et al.
Veröffentlicht: (2008)

A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
von: Júlia Companys-Alemany, et al.
Veröffentlicht: (2020)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
von: Ameng Shi, et al.
Veröffentlicht: (2021)

Challenges and risks of using GLP-1 antagonists in treating type 2 diabetes and obesity
von: Agnieszka Głuszczyk, et al.
Veröffentlicht: (2024)

NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysis
von: Marie-Lou, et al.
Veröffentlicht: (2024)

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer's Disease, in Silico Trials
von: Dariusz Świetlik, et al.
Veröffentlicht: (2022)

Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patients
von: Thomas Monfeuga, et al.
Veröffentlicht: (2024)

Behavioral Consequences of a Combination of Gad1 Haplodeficiency and Adolescent Exposure to an NMDA Receptor Antagonist in Long-Evans Rats
von: Kazuyuki Fujihara, et al.
Veröffentlicht: (2021)

Memantine, an antagonist of the NMDA glutamate receptor, affects cell proliferation, differentiation and the intracellular cycle and induces apoptosis in Trypanosoma cruzi.
von: Flávia Silva Damasceno, et al.
Veröffentlicht: (2014)

NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans
von: Sara de la Salle, et al.
Veröffentlicht: (2019)

Inducible nitric oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux
von: Hadley C Bergstrom, et al.
Veröffentlicht: (2015)

Analysis of Adverse Events of Cholinesterase Inhibitors and NMDA Receptor Antagonists on Arrhythmias Using the Japanese Adverse Drug Event Report Database
von: Shotaro Kobayashi, et al.
Veröffentlicht: (2023)

Low-Affinity NMDA Receptor Antagonist Hemantane in a Topical Formulation Attenuates Arthritis Induced by Freund's Complete Adjuvant in Rats
von: Elena Ivanova, et al.
Veröffentlicht: (2024)

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity
von: Douglas Bledsoe, et al.
Veröffentlicht: (2017)

Non-competitive NMDA antagonist MK-801 prevents memory reconsolidation impairment caused by protein synthesis inhibitors in young chicks
von: A. A. Tiunova, et al.
Veröffentlicht: (2024)

Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion
von: Brandon L. Panaro, et al.
Veröffentlicht: (2020)

Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites
von: Mari L. Lund, et al.
Veröffentlicht: (2018)

The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
von: Jason M. Ridlon, et al.
Veröffentlicht: (2015)

How gut microbes talk to organs: The role of endocrine and nervous routes
von: Patrice D. Cani, et al.
Veröffentlicht: (2016)

Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat
von: Helen L. Williams, et al.
Veröffentlicht: (2013)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
von: M S Kamath, et al.
Veröffentlicht: (2008)

Herpes Simplex and NMDA Encephalitides
von: J Gordon Millichap, et al.
Veröffentlicht: (2014)

Osmoadaptive GLP-1R signalling in hypothalamic neurones inhibits antidiuretic hormone synthesis and release
von: Michael P. Greenwood, et al.
Veröffentlicht: (2023)

Generalization of NMDA-Receptor Antagonists to the Discriminative Stimulus Effects of κ-Opioid Receptor Agonists U-50,488H, but Not TRK-820 in Rats
von: Tomohisa Mori, et al.
Veröffentlicht: (2006)

Seizures and Anti-NMDA-Receptor Encephalitis
von: J Gordon Millichap
Veröffentlicht: (2008)

Allosteric Inhibitors of NMDA Receptor Functions
von: William F. Borschel, et al.
Veröffentlicht: (2010)

Exploring the role of NMDA receptor in memory
von: Pooja Tiwary, et al.
Veröffentlicht: (2023)

GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota
von: Thomas U. Greiner, et al.
Veröffentlicht: (2024)

The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver
von: Ewa Bromek, et al.
Veröffentlicht: (2021)

Recent findings within the microbiota–gut–brain–endocrine metabolic interactome
von: Obrenovich M, et al.
Veröffentlicht: (2017)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
von: Kristof Chwalisz, M.D., Ph.D
Veröffentlicht: (2023)

The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice
von: Mireia Montaner, et al.
Veröffentlicht: (2023)

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
von: Heng Wu, et al.
Veröffentlicht: (2023)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
von: Li Yang, et al.
Veröffentlicht: (2021)

Investigating the L-Glu-NMDA receptor-H2S-NMDA receptor pathway that regulates gastric function in rats' nucleus ambiguus
von: Hongzhao Sun, et al.
Veröffentlicht: (2024)